You are here » Home » Companies » Company Overview » Brooks Laboratories Ltd

Brooks Laboratories Ltd.

BSE: 533543 Sector: Health care
NSE: BROOKS ISIN Code: INE650L01011
BSE 00:00 | 17 Aug 79.70 0.80
(1.01%)
OPEN

80.50

HIGH

83.50

LOW

79.50

NSE 00:00 | 17 Aug 79.85 0.20
(0.25%)
OPEN

81.15

HIGH

83.80

LOW

79.50

OPEN 80.50
PREVIOUS CLOSE 78.90
VOLUME 19995
52-Week high 126.85
52-Week low 74.30
P/E
Mkt Cap.(Rs cr) 129
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 80.50
CLOSE 78.90
VOLUME 19995
52-Week high 126.85
52-Week low 74.30
P/E
Mkt Cap.(Rs cr) 129
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Brooks Laboratories Ltd. (BROOKS) - Chairman Speech

Company chairman speech

Dear Shareholders

Last few years have been particularly challenging for our industry in India as well asglobally. The pharmaceutical industry is witnessing a slow rate of growth due to factorslike increasing regulatory & compliance issues and pricing pressures across markets.There were several changes in the pharmaceutical eco-system.

However despite all these challenges and changes we stand strong. During the year weidentified several improvement areas in our current processes and capacities which willgive us encouraging outcomes in the near future.

We also laid emphasis on building our base by automating our processes as our marketsgot tougher in regulations. We are not only adhering to new tougher regulations but alsoexpanding our capacities too as we have better demand. So we are directed in our effortstowards strengthening our core capabilities through a stronger focus on better technologywith enhanced capacities.

In the future too we shall continue to increase our current capacities make ourpresence felt in the international markets though international highly regulated marketstake their own sweet time for approvals and registrations we at Brooks are leaving nostone unturned to keep it going at best possible pace with our serious efforts andcontinuous improvement through focus on global compliances with better quality andprocesses.

We remain optimistic and continue to act with resilience. With commencement ofoperations at Vadodara 2017-18 is an important year for the organisation and we areexcited to have you on board in this journey with us. As we move towards the new growthtrajectory we remain committed to build a strong organisation. We strive to create aculture that attracts and retains the best talent as we look to expand our globalfootprints.

At Brooks we have always been committed for patients across the world and towardscreating value to our stakeholders. Although the year under review has been challengingyour organisation remains well poised for continuous and sustained growth. Our aim is totransform the organisation to an innovative company and deliver our best.

Keeping the above in mind we strive to maintain our excellence in quality safety andcompliance at Baddi and Vadodara facilities. We will continue to deliver on yourexpectations with increased profitability and improved cash flows in the coming years.Your continuous support towards the Company's endeavours and the commitment of ouroutstanding employees gives me immense faith and confidence in the future of our Company.

Place: Mumbai Atul Ranchal
Date: 02.09.2017 Chairman Brooks Laboratories Ltd.